• Nachrichtendetail
• 

31.05.2024 07:04:41 - dpa-AFX: *REGENERON: FDA EXTENDS TARGET ACTION DATE OF SBLA FOR DUPIXENT FOR COPD PATIENTS WITH TYPE 2 INFLAMMATION BY THREE MONTHS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	Regeneron Pharmaceuticals	881535	NASDAQ	1.054,230	09.07.24 21:46:08	+1,980	+0,19%	1.054,390	1.055,470	1.055,830	1.052,250